Target intelligence / Profile preview

Jumonji Domain Containing Histone Demethylase (JmjC-KDM)

Target
JmjC-KDM
Molecular classification
Enzyme, Histone modification
01

Overview

Jumonji domain-containing histone demethylases (JmjC-KDMs) are a family of enzymes that catalyze the removal of methyl groups from lysine residues on histone proteins. This demethylation process is crucial for regulating chromatin structure and, consequently, gene expression. The activity of these enzymes requires Fe(2+) and α-ketoglutarate as cofactors. Alterations in Jumonji domain-containing demethylases have been implicated in various human cancers due to their role in epigenetic regulation. As such, they are considered emerging therapeutic targets for anticancer drug development.

Other names
JHDMJumonji C domain-containing demethylases
02

Mechanism of action

Inhibition of histone demethylase activity, leading to altered gene expression.

03

Biological functions

Gene regulationChromatin remodelingTranscriptional activationTranscriptional repressionEpigenetic regulation
04

Disease associations

Cancer
05

Safety considerations

Potential for off-target effects due to homology between JmjC-KDMsPotential for dysregulation of other epigenetic processes
06

Interacting drugs

Methylstat

Beyond the preview

Go deeper on Jumonji Domain Containing Histone Demethylase (JmjC-KDM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jumonji Domain Containing Histone Demethylase (JmjC-KDM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call